Our findings suggest, however, that cleavage of βig-H3 in the ovarian cancer and peritoneal cell co-culture is not MMP mediated as the broad spectrum MMP inhibitor, GM6001, failed to inhibit βig-H3 processing. The gene discussed is TGFBI; the disease is ovarian carcinoma.